Multiple roles and therapeutic implications of Akt signaling in cancer

por Calvo, Emiliano, Bolós, Victoria, Grande, Enrique
Publicado 2009

Thyroid Cancer: Molecular Aspects and New Therapeutic Strategies

por Grande, Enrique, Díez, Juan José, Zafon, Carles, Capdevila, Jaume
Publicado 2012

The dual kinase complex FAK-Src as a promising therapeutic target in cancer

por Bolós, Victoria, Gasent, Joan Manuel, López-Tarruella, Sara, Grande, Enrique
Publicado 2010

Emerging use of everolimus in the treatment of neuroendocrine tumors

por Gajate, Pablo, Martínez-Sáez, Olga, Alonso-Gordoa, Teresa, Grande, Enrique
Publicado 2017

Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation

por Molina-Cerrillo, Javier, Alonso-Gordoa, Teresa, Carrato, Alfredo, Grande, Enrique
Publicado 2020

Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation

por Molina-Cerrillo, Javier, Alonso-Gordoa, Teresa, Carrato, Alfredo, Grande, Enrique
Publicado 2022

A significant response to sunitinib in a patient with anaplastic thyroid carcinoma

por Grande, Enrique, Capdevila, Jaume, Díez, Juan José, Longo, Federico, Carrato, Alfredo
Publicado 2013

Translating new data to the daily practice in second line treatment of renal cell carcinoma: The role of tumor growth rate

por Grande, Enrique, Martínez-Sáez, Olga, Gajate-Borau, Pablo, Alonso-Gordoa, Teresa
Publicado 2017

Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis...

por Sevilla, Isabel, Segura, Ángel, Capdevila, Jaume, López, Carlos, García-Carbonero, Rocío, Grande, Enrique
Publicado 2016

Living with Cancer: Through the Eyes of the Patient and the Physician

por Vigo, José Manuel, Fonseca, Paula Jiménez, Calderon, Caterina, Carmona-Bayonas, Alberto, Grande, Enrique
Publicado 2016

May Ibrutinib Have Activity in Respiratory Complications by SARS-CoV-2? Clinical Experience in a Patient with Chronic Lymphocytic Leukemia

por Molina-Cerrillo, Javier, Marquet-Palomanes, Juan, Alonso-Gordoa, Teresa, López-Jiménez, Javier, Grande, Enrique
Publicado 2021

Current perspectives on the management of patients with advanced RET-driven thyroid cancer in Europe

por Elisei, Rossella, Grande, Enrique, Kreissl, Michael C., Leboulleux, Sophie, Puri, Tarun, Fasnacht, Nicolas, Capdevila, Jaume
Publicado 2023

Crossing Paths in Human Renal Cell Carcinoma (hRCC)

por Gallego, Guadalupe Aparicio, Villaamil, Vanessa Medina, Grande, Enrique, Caínzos, Isabel Santamarina, Antón Aparicio, Luís M.
Publicado 2012

An Overview on the Sequential Treatment of Pancreatic Neuroendocrine Tumors (pNETs)

por Alonso-Gordoa, Teresa, Díez, Juan José, Molina, Javier, Reguera, Pablo, Martínez-Sáez, Olga, Grande, Enrique
Publicado 2015

Differential diagnosis of diarrhoea in patients with neuroendocrine tumours: A systematic review

por Khan, Mohid S, Walter, Thomas, Buchanan-Hughes, Amy, Worthington, Emma, Keeber, Lucie, Feuilly, Marion, Grande, Enrique
Publicado 2020

Huge recurrent gastric neuroendocrine tumor: a second-line chemotherapeutic dilemma

por Ribeiro, Maria João Marques, Alonso, Teresa, Gajate, Pablo, Molina, Javier, Barquin, Arantzazu, Perna, Cristian, Grande, Enrique
Publicado 2018

Targeting Tyrosine kinases in Renal Cell Carcinoma: “New Bullets against Old Guys”

por Alonso-Gordoa, Teresa, García-Bermejo, María Laura, Grande, Enrique, Garrido, Pilar, Carrato, Alfredo, Molina-Cerrillo, Javier
Publicado 2019

Effect of capmatinib on the pharmacokinetics of digoxin and rosuvastatin administered as a 2‐drug cocktail in patients with MET‐dysregulated advanced solid tumours: A phase I, mult...

por Grande, Enrique, Giovannini, Monica, Marriere, Eddie, Pultar, Philippe, Quinlan, Michelle, Chen, Xinhui, Rahmanzadeh, Gholamreza, Curigliano, Giuseppe, Cui, Xiaoming
Publicado 2020

A phase Ib dose-escalation and expansion study of the oral MEK inhibitor pimasertib and PI3K/MTOR inhibitor voxtalisib in patients with advanced solid tumours

por Schram, Alison M., Gandhi, Leena, Mita, Monica M., Damstrup, Lars, Campana, Frank, Hidalgo, Manuel, Grande, Enrique, Hyman, David M., Heist, Rebecca S.
Publicado 2018

Current and Future Role of Tyrosine Kinases Inhibition in Thyroid Cancer: From Biology to Therapy

por San Román Gil, María, Pozas, Javier, Molina-Cerrillo, Javier, Gómez, Joaquín, Pian, Héctor, Pozas, Miguel, Carrato, Alfredo, Grande, Enrique, Alonso-Gordoa, Teresa
Publicado 2020